Abby Macnish Niven
CFO & Company SecretaryMs. Abby Macnish Niven, BComm, B.Sc, CFA, GAICD, serves as Company Secretary at Paradigm Biopharmaceuticals Limited and was its Chief Financial Officer until January 1, 2026. she also serves as Chief Financial Officer at Paradigm Biopharmaceuticals Limited. She serves as Chief Financial Officer of Alterity Therapeutics Limited since September 30, 2024 and serves as its Company Secretary from November 18, 2024. She served as Company Secretary at NeuroScientific Biopharmaceuticals Limited since April 20, 2020 until 2024 and also served as Chief Financial Officer until 2024. She served as an Interim Company Secretary at Paradigm Biopharmaceuticals Limited since August 30, 2022 and served as its Interim Chief Financial Officer since March 3, 2023 and served as Director. She served as Co-Company Secretary of NeuroScientific Biopharmaceuticals Ltd since February 3, 2020 until April 20, 2020. She is a Member of the Australian Institute of Company Directors. She has also completed the Certificate in Governance Practice. She is also the Chair of the Investment Committee at TWD Australia and a board member for Muscular Dystrophy WA (MDWA), a charity with the aim of supporting the MDWA community. She holds Bachelor of Commerce and Bachelor of Science degrees from the University of Western Australia, is a CFA charter holder and has experience in investments and equity markets. She was Company Secretary of Tombador Iron Limited since April 2020 and serves as its Chief Financial Officer Since May 01, 2020. She was Company Secretary of Atomic Eagle Limited since May 01, 2020 until October 16, 2026. She was Chief Financial Officer at Atomic Eagle Limited until December 31, 2025.
Positions
- Company NameAlterity Therapeutics LimitedStock CodeATHEPositionCFO & Company SecretaryColleagues
- DADavid A. StamlerCEO, MD & Director
- JBJulian BabarczyIndependent Non-Executive Chair
- RERudolph Emile TanziChief Scientific Advisor and Member of Research & Development Advisory Board
- SDSteven D. TargumChief Medical Advisor
- RCRobert ChernyHead of Research
- PAPeter Ashley MarksNon-Executive Independent Director
- ISIra ShoulsonChairman of Research & Development Advisory Board
